 |
|
Race, Quality of Care, and Outcomes of Elderly Patients Hospitalized With Heart Failure
Saif S. Rathore, MPH;
JoAnne M. Foody, MD;
Yongfei Wang, MS;
Grace L. Smith, MPH;
Jeph Herrin, PhD;
Frederick A. Masoudi, MD, MSPH;
Pamela Wolfe, MS;
Edward P. Havranek, MD;
Diana L. Ordin, MD, MPH;
Harlan M. Krumholz, MD, SM
JAMA. 2003;289:2517-2524.
Context Black patients hospitalized with heart failure reportedly receive poorer quality of care and have worse outcomes than white patients. Because previous studies have been based on selected patient populations treated more than a decade ago, it is unclear if racial differences in quality of care and outcomes currently exist in the United States.
Objective To evaluate differences in quality of care and patient outcomes between black and white Medicare beneficiaries hospitalized with heart failure.
Design Retrospective analysis of medical record data systematically collected for the National Heart Failure Project.
Setting and Patients Nationwide US sample of 29 732 fee-for-service Medicare beneficiaries hospitalized with heart failure in 1998 and 1999.
Main Outcome Measures Prescription of angiotensin-converting enzyme (ACE) inhibitors, measurement of left ventricular ejection fraction (LVEF), readmission within 1 year of discharge, and mortality within 30 days and 1 year of admission.
Results Black patients and white patients had similar crude rates of LVEF assessment (67.8% black vs 66.6% white; P = .29). Among patients classified as ideal for ACE inhibitor use, black patients had higher crude rates of ACE inhibitor use than white patients (81.0% vs 73.8% white; P<.001) but had similar rates of ACE inhibitor or angiotensin receptor blocker (ARB) use (85.7% black vs 82.5% white; P = .08). After multivariable adjustment, black patients had comparable rates of LVEF assessment (risk ratio [RR], 0.99; 95% confidence interval [CI], 0.95-1.03). Black patients remained more likely to be prescribed ACE inhibitors (RR, 1.22; 95% CI, 1.14-1.28) than were white patients in an adjusted analysis, but there were no significant racial differences in the prescription of ACE inhibitors or ARBs (black vs white, RR, 1.03; 95% CI, 0.97-1.07). Black patients had higher rates of readmission within 1 year of discharge (68.2% vs 63.0%; P<.001) but had lower crude 30-day (6.3% vs 10.7%; P<.001) and 1-year (31.5% vs 40.1%; P<.001) mortality rates than white patients. After multivariable adjustment, black patients had a slightly higher rate of readmission than white patients (RR, 1.09; 95% CI, 1.06-1.13) but remained at lower risk of 30-day mortality (RR, 0.78; 95% CI, 0.68-0.91) and 1-year mortality (RR, 0.93; 95% CI, 0.88-0.98).
Conclusions Black Medicare patients hospitalized with heart failure received comparable quality of care and had slightly higher rates of readmission but had lower mortality rates up to 1 year after hospitalization than did white patients.
Author Affiliations: Section of Cardiovascular Medicine, Department of Internal Medicine (Messrs Rathore and Wang, Drs Foody and Krumholz, and Ms Smith) and Section of Health Policy and Administration, Department of Epidemiology and Public Health (Dr Krumholz), Yale University School of Medicine, New Haven, Conn; Flying Buttress Associates, Charlottesville, Va (Dr Herrin); Division of Cardiology, Department of Medicine, Denver Health Medical Center (Drs Masoudi and Havranek), and Divisions of Geriatric Medicine (Dr Masoudi) and Cardiology (Drs Masoudi and Havranek), Department of Medicine, University of Colorado Health Sciences Center, Denver; Colorado Foundation for Medical Care, Aurora (Drs Masoudi and Havranek and Ms Wolfe); and the Centers for Medicare & Medicaid Services, Boston, Mass (Dr Ordin).
RELATED LETTER
Racial Disparities in Care of Heart Failure
Dawn FitzGerald
JAMA. 2003;290(10):1316.
EXTRACT
| FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Predictors of In-Hospital Mortality in Patients Hospitalized for Heart Failure: Insights From the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients With Heart Failure (OPTIMIZE-HF)
Abraham et al.
J Am Coll Cardiol 2008;52:347-356.
ABSTRACT
| FULL TEXT
Statistical Models and Patient Predictors of Readmission for Heart Failure: A Systematic Review
Ross et al.
Arch Intern Med 2008;168:1371-1386.
ABSTRACT
| FULL TEXT
Characteristics and Outcomes in African American Patients With Decompensated Heart Failure
Kamath et al.
Arch Intern Med 2008;168:1152-1158.
ABSTRACT
| FULL TEXT
Diabetes, left ventricular systolic dysfunction, and chronic heart failure
MacDonald et al.
Eur Heart J 2008;29:1224-1240.
ABSTRACT
| FULL TEXT
Quality of Care of and Outcomes for African Americans Hospitalized With Heart Failure: Findings From the OPTIMIZE-HF (Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients With Heart Failure) Registry
Yancy et al.
J Am Coll Cardiol 2008;51:1675-1684.
ABSTRACT
| FULL TEXT
Do Hospitals Provide Lower-Quality Care To Minorities Than To Whites?
Gaskin et al.
Health Aff (Millwood) 2008;27:518-527.
ABSTRACT
| FULL TEXT
BiDil for Heart Failure in Black Patients: Implications of the U.S. Food and Drug Administration Approval
Bibbins-Domingo and Fernandez
ANN INTERN MED 2007;146:52-56.
ABSTRACT
| FULL TEXT
An Administrative Claims Model Suitable for Profiling Hospital Performance Based on 30-Day Mortality Rates Among Patients With Heart Failure
Krumholz et al.
Circulation 2006;113:1693-1701.
ABSTRACT
| FULL TEXT
Ethnicity and variation in prognosis for patients newly hospitalised for heart failure: a matched historical cohort study
Newton et al.
Heart 2005;91:1545-1550.
ABSTRACT
| FULL TEXT
Quality of Care and Outcomes of Older Patients With Heart Failure Hospitalized in the United States and Canada
Ko et al.
Arch Intern Med 2005;165:2486-2492.
ABSTRACT
| FULL TEXT
Incremental Effects of Concurrent Pharmacotherapeutic Regimens for Heart Failure on Hospitalizations and Costs
Skrepnek et al.
The Annals of Pharmacotherapy 2005;39:1785-1791.
ABSTRACT
| FULL TEXT
Explaining Black-White Differences in Receipt of Recommended Colon Cancer Treatment
Baldwin et al.
JNCI J Natl Cancer Inst 2005;97:1211-1220.
ABSTRACT
| FULL TEXT
Adherence to guidelines is a predictor of outcome in chronic heart failure: the MAHLER survey
Komajda et al.
Eur Heart J 2005;26:1653-1659.
ABSTRACT
| FULL TEXT
Adoption of Spironolactone Therapy for Older Patients With Heart Failure and Left Ventricular Systolic Dysfunction in the United States, 1998-2001
Masoudi et al.
Circulation 2005;112:39-47.
ABSTRACT
| FULL TEXT
Racial Variations in Treatment and Outcomes of Black and White Patients With High-Risk Non-ST-Elevation Acute Coronary Syndromes: Insights From CRUSADE (Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse Outcomes With Early Implementation of the ACC/AHA Guidelines?)
Sonel et al.
Circulation 2005;111:1225-1232.
ABSTRACT
| FULL TEXT
Critical Care Use during the Course of Serious Illness
Iwashyna
Am. J. Respir. Crit. Care Med. 2004;170:981-986.
ABSTRACT
| FULL TEXT
Differences, Disparities, and Biases: Clarifying Racial Variations in Health Care Use
Rathore and Krumholz
ANN INTERN MED 2004;141:635-638.
ABSTRACT
| FULL TEXT
Racial Disparities in Hospitalized Elderly Patients with Chronic Heart Failure
Wheeler et al.
J Transcult Nurs 2004;15:291-297.
ABSTRACT
The year in health care delivery and outcomes research
Krumholz
J Am Coll Cardiol 2004;44:1130-1136.
FULL TEXT
Impact of race on health care utilization and outcomes in veterans with congestive heart failure
Deswal et al.
J Am Coll Cardiol 2004;43:778-784.
ABSTRACT
| FULL TEXT
Racing away from bias
Sackner-Bernstein and Skopicki
J Am Coll Cardiol 2004;43:785-786.
FULL TEXT
What we're talking about when we talk about race
Havranek and Masoudi
J Am Coll Cardiol 2004;43:436-437.
FULL TEXT
Racial Disparities in Care of Heart Failure
FitzGerald
JAMA 2003;290:1316-1316.
FULL TEXT
|
